You are here

advisory committees

FDA advisers to weigh first psychedelic therapy in early June

Fierce Biotech

Tue, 05/7/24 - 11:23 am

Lykos Therapeutics

psychedelic drugs

advisory committees

Lilly gets a date with FDA to discuss Alzheimer's med donanemab

Fierce Biotech

Tue, 05/7/24 - 11:21 am

advisory committees

Alzheimer's disease

Eli Lilly Gears Up for Donanemab Adcomm as FDA Ponders Changes to Format

BioSpace

Mon, 05/6/24 - 11:43 am

advisory committees

Alzheimer's disease

FDA Creates Adcomm for Genetic Metabolic Diseases and Potential Treatments

BioSpace

Wed, 12/13/23 - 09:34 am

advisory committees

genetic metabolic diseases

After quitting FDA adcomm in protest of Aduhelm decision, Harvard's Aaron Kesselheim finds agency has an approval bias

Fierce Pharma

Mon, 07/31/23 - 10:07 am

Alzheimer's disease

advisory committees

Uptick in FDA adcomms coming in 2023 as CDER hiring picks up, Cavazzoni says

Endpoints

Wed, 04/5/23 - 07:12 pm

advisory committees